Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics

Journal article 1131 views 220 downloads

Patrícia R.S. Rodrigues, Noemi Picco

, B Paul Morgan, Peter Ghazal

Expert Opinion on Drug Discovery, Volume: 16, Issue: 5, Pages: 537 - 551

Swansea University Author: Noemi Picco

PDF | Version of Record

© 2020 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License
Download (4.39MB)

DOI (Published version): 10.1080/17460441.2021.1851186

Published in:	Expert Opinion on Drug Discovery
ISSN:	1746-0441 1746-045X
Published:	Informa UK Limited 2021
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa55698

Keywords:	Anaphylatoxins; c5a; complement; immune checkpoint; pattern recognition molecules (PRMs); sepsis; t-cell dysfunction; biologic-therapy
College:	Faculty of Science and Engineering
Issue:	5
Start Page:	537
End Page:	551